Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008–present)
出版年份 2012 全文链接
标题
Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008–present)
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 22, Issue 7, Pages 803-841
出版商
Informa Healthcare
发表日期
2012-06-15
DOI
10.1517/13543776.2012.699042
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
- (2012) A. Neumann et al. DIABETOLOGIA
- Nuclear receptors as pharmaceutical targets: rise of FXR and rebirth of PPAR?
- (2012) Daniel Merk et al. Future Medicinal Chemistry
- New Insights into the Role of Peroxisome Proliferator-Activated Receptors in Regulating the Inflammatory Response after Tissue Injury
- (2012) Miriam D. Neher et al. PPAR Research
- Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
- (2011) Jang Hyun Choi et al. NATURE
- Safer PPARγ-targeted drugs on the horizon?
- (2011) Sarah Crunkhorn NATURE REVIEWS DRUG DISCOVERY
- PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects
- (2010) Mi-Kyung Kim et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon
- (2010) L. Peyrin-Biroulet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PAR-1622 is a selective peroxisome proliferator-activated receptor γ partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention
- (2009) Mi-Kyung Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Discovery of a novel class of 2-mercaptohexanoic acid derivatives as highly active PPARα agonists
- (2009) Heiko Zettl et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structural Basis for the Design of PPAR-γ Ligands: A Survey on Quantitative Structure- Activity Relationships
- (2009) Costas Giaginis et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- PPAR Modulators and PPAR Pan Agonists for Metabolic Diseases: The Next Generation of Drugs Targeting Peroxisome Proliferator-Activated Receptors?
- (2008) P. Feldman et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Anti-tumour activity of CS-7017, a selective peroxisome proliferator-activated receptor gamma agonist of thiazolidinedione class, in human tumour xenografts and a syngeneic tumour implant model
- (2008) Naomi Shimazaki et al. EUROPEAN JOURNAL OF CANCER
- PAR-5359, a well-balanced PPARα/γ dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo
- (2008) Mi-Kyung Kim et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Thematic Review Series: Skin Lipids.Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology
- (2008) Matthias Schmuth et al. JOURNAL OF LIPID RESEARCH
- Identification and Characterization of a Selective Peroxisome Proliferator-Activated Receptor β/δ (NR1C2) Antagonist
- (2007) Barry G. Shearer et al. MOLECULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More